Cullinan Therapeutics, Inc.

CGEM Healthcare Biotechnology

In the quarter to June 2026, EPS grew 24.3% and free cash flow grew 33.7%, each against the same quarter a year earlier.

12.93 1.07 −7.64%
Market cap
$901.0M
P/E
0.0×
Fwd P/E
4.8×
Dividend yield
—
F-score
n/a
Altman Z
33.57
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash and Short Term Investments
377.90 398.98 467.07 467.29 290.47 210.21 98.63
Total current assets
386.76 414.67 480.19 474.47 296.56 212.28 100.09
Property, Plant, Equpment (Net)
0.42 0.68 0.99 1.17 0.08 0.13 0.18
Long-Term Investments
58.27 204.44 — 80.88 140.40 — —
Long-term assets (Other)
0.30 0.37 0.46 0.46 0.15 2.30 0.19
Total non-current assets
61.62 207.16 3.99 86.65 140.62 2.43 0.37
Total Assets
448.37 621.82 484.18 561.12 437.19 214.71 100.46
Accounts Payable
0.84 1.68 2.49 2.66 3.17 9.68 0.93
Accrued Expenses
36.12 27.66 24.20 14.14 8.58 4.64 1.59
Current Part of Taxes to Pay
— — — 4.28 0.00 — —
Total current liabilities
37.74 30.65 28.14 22.50 11.75 14.32 2.52
Preferred Shares of Subsidiary (Mandatory, Redeemable)
— — — — — 276.65 137.77
Non-current Liabilities (Other)
— — — — 0.07 0.07 0.07
Total non-current liabilities
1.90 0.85 2.15 3.59 0.07 0.07 137.85
Total liabilities
39.64 31.50 30.29 26.09 11.81 14.39 140.37
Additional Paid In Capital
995.82 958.70 654.69 585.32 584.71 292.35 0.77
Common Stock (Net)
0.01 0.01 0.00 0.01 0.00 0.00 0.00
Retained Earnings
(588.12) (368.24) (200.86) (47.69) (158.91) (93.34) (41.54)
Shareholders Equity (Other)
— — — — — 0.00 0.00
Common Equity (Total)
408.73 590.33 453.90 535.03 425.37 200.31 (39.91)
Shareholders Equity (Total)
408.73 590.33 453.90 535.03 425.37 200.31 (39.91)
Shareholders Equity and Liabilities (Total)
448.37 621.82 484.18 561.12 437.19 214.71 100.46
Shares (Common)
60.24 58.51 42.90 45.80 44.29 29.83 —
Shares (Preferred)
0.56 0.65 0.65 0.00 — — —
Shareholders Equity (Tangible)
408.73 590.33 453.90 535.03 425.37 200.31 (39.91)
Net Debt
(377.90) (398.98) (467.07) (467.29) (290.47) (210.21) (98.63)

Fold the line items

In millions of $ except per-share values · columns are period end dates